20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T64392 | PI3K-IN-46 | PI3K | |
PI3K-IN-46 is a specific inhibitor of PI3Kγ. | |||
T12459 | PI3K/mTOR Inhibitor-2 | PI3K , mTOR | |
PI3K/mTOR Inhibitor-2 is a potent pan inhibitor of PI3K and mTOR with IC50s of 3.4, 34, 16,1 and 4.7 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR. PI3K/mTOR Inhibitor-2 has antitumor activity. | |||
T12365 | PARP/PI3K-IN-1 | PARP , PI3K | |
PARP/PI3K-IN-1 is a novel dual poly (ADP-ribose) polymerase (PARP) and phosphatidylinositol 3-kinase (PI3K) dual inhibitor with anticancer, antitumour and antiproliferative activities for the study of breast, pancreatic ... | |||
T1826 | PI3K-IN-1 | Voxtalisib Analogue,Voxtalisib (SAR245409, XL765) Analogue,XL765,SAR245409 | DNA-PK , PI3K |
PI3K-IN-1 (Voxtalisib Analogue) is a dual inhibitor of mTOR/PI3K, mostly for p110γ , also inhibits DNA-PK and mTOR. | |||
T61618 | PI3K-IN-38 | PI3K | |
PI3K-IN-38 is an orally available and potent PI3K inhibitor with an IC50 value of 0.541 µM for PI3K-α. PI3K-IN-38 exhibits anticancer and anti-inflammatory activity and inhibits tumor growth in vivo. | |||
T39581 | PI3K-IN-19 hydrochloride | PI3K-IN-19 hydrochloride | |
PI3K-IN-19 hydrochloride (WO2017153220, step 5) acts as a phosphatidylinositol-3-kinase (PI3K) inhibitor. | |||
T2265 | Bimiralisib | 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine,PQR309,PI3K-IN-2 | Others , PI3K , S6 Kinase , mTOR |
Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to ... | |||
T24637 | PI3K inhibitor C 96 | PI3K IN C96,PI3K-IN-C96 | |
PI3K inhibitor C 96 is an inhibitor of phosphatidylinositol 3-kinase. It shows effective activity against multiple myeloma in vitro and in vivo. | |||
T60564 | PI3K/Akt/mTOR-IN-2 | Apoptosis , Akt , PI3K , mTOR | |
PI3K/Akt/mTOR-IN-2 is a potent PI3K/AKT/mTOR inhibitor.PI3K/Akt/mTOR-IN-2 has anticancer effects and is selective for MDA-MB-231 cells with an IC50 of 2.29 μM.PI3K/Akt/mTOR-IN-2 exhibits anticancer activity and induces c... | |||
T2078 | Fimepinostat | CUDC-907,PI3K/HDAC Inhibitor,CUDC 907 | Apoptosis , PI3K , HDAC |
Fimepinostat (CUDC 907) is an orally bioavailable inhibitor of both phosphoinositide 3-kinase (PI3K) class I and pan-histone deacetylase (HDAC) enzymes, with potential antineoplastic activity. Upon oral administration, C... | |||
T36087 | PI3K-IN-22 | CAY10626 | |
PI3K-IN-22 is a dual kinase inhibitor of PI3Kα and mTOR, with IC50s of 0.9 and 0.6 nM respectively. PI3K-IN-22 could be used in cancer. | |||
T12456 | PI3K-IN-10 | PI3K | |
PI3K-IN-10 is a potent inhibitor of pan-PI3K . | |||
T12457 | PI3K-IN-6 | PI3K | |
PI3K-IN-6 is an oral active and highly selective inhibitor of phosphoinositide 3-kinase (PI3K) β/δ(IC50 values of 7.8 nM/5.3 nM , respectively). | |||
T12458 | PI3K-IN-9 | PI3K | |
PI3K-IN-9 is a potent and selective inhibitor of PI3Kδ(IC50 of 8.9 nM). | |||
T12455 | PI3K/HDAC-IN-1 | PI3K | |
PI3K/HDAC-IN-1 is a potent PI3K and HDAC dual inhibitor(IC50s of 8.1 nM and 1.4 nM, respectively). | |||
T12460 | PI3K/mTOR Inhibitor-1 | PI3K | |
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM) | |||
T71272 | PI3K/Akt-IN-C89 | ||
PI3K/Akt-IN-C89 is a novel Inhibitor of the PI3K-Akt Pathway, Inducing Autophagy of Female Germline Stem Cells. | |||
T62580 | PI3K-IN-37 | ||
PI3K-IN-37 (Example 84.1) is an inhibitor of PI3K α (IC50: 6 nM), PI3K β (IC50: 8 nM) and PI3K δ (IC50: 4 nM). PI3K-IN-37 inhibits mTOR with an IC50 value of 4 nM. | |||
T73150 | PI3K-IN-36 | ||
PI3K-IN-36 is a potent inhibitor of PI3K, suitable for research applications in follicular lymphoma (FL). | |||
T64052 | PI3K-IN-27 | ||
PI3K-IN-27 is a potent inhibitor of PI3K, a large family of lipid signalling kinases that play a key role in cellular processes such as cell growth, differentiation, migration and apoptosis. PI3K-IN-27 has shown research... |